Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women

International Journal of Cancer

Volumn 129, Issue 9, 2011, Pages 2218-2225

  Overmeer, Renée M ^a   Louwers, Jacqueline A ^a   Meijer, Chris J L M ^a   Van Kemenade, Folkert J ^a   Hesselink, Albertus T ^a   Daalmeijer, Nathalie Fransen ^a   Wilting, Saskia M ^a   Heideman, Daniëlle A M ^a   Verheijen, René H M ^b   Zaal, Afra ^b   Marchien Van Baal, W ^a   Berkhof, Johannes ^a   Snijders, Peter J F ^a   Steenbergen, Renske D M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

cervical cancer; detection CIN3+; HPV; methylation markers

Indexed keywords

ADULT; AGED; ARTICLE; CADM1 GENE; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA METHYLATION; ELECTROSURGERY; FEMALE; GENE; GENETIC MARKER; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAL GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERUS BIOPSY; WART VIRUS;

ADOLESCENT; ADULT; AGED; CELL ADHESION MOLECULES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; DNA METHYLATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOGLOBULINS; MIDDLE AGED; MYELIN AND LYMPHOCYTE-ASSOCIATED PROTEOLIPID PROTEINS; NEOPLASM GRADING; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 80052269041     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25890     Document Type: Article

References (29)

1. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van GK, Boon ME, Ruitinga W, van BM, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 1764-72. (Pubitemid 350137476)
2. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
3. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, Radberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007; 357: 1589-97. (Pubitemid 47598401)
4. Cuzick J,. Long-term follow-up in cancer prevention trials (It ain't over 'til it's over). Cancer Prev Res (Phila) 2010; 3: 689-91.
5. Wentzensen N, Sherman ME, Schiffman M, Wang SS,. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 2009; 112: 293-9.
6. Overmeer RM, Henken FE, Bierkens M, Wilting SM, Timmerman I, Meijer CJ, Snijders PJ, Steenbergen RD,. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 2009; 219: 327-36.
7. Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, van der Zee AG,. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 2006; 119: 1908-14. (Pubitemid 44356850)
8. Kahn SL, Ronnett BM, Gravitt PE, Gustafson KS,. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. Cancer 2008; 114: 57-64. (Pubitemid 351304613)
9. Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ,. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004; 96: 294-305. (Pubitemid 38256274)
10. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan MW, Chu TY, Sun CA, Chang CC, Yu MH,. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 2008; 123: 161-7. (Pubitemid 351705204)
11. Gustafson KS, Furth EE, Heitjan DF, Fansler ZB, Clark DP,. DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis. Cancer 2004; 102: 259-68. (Pubitemid 39097157)
12. Wang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, Cho KR, Bonfiglio TA, Nayar R, Plass C, Sherman ME,. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res 2008; 68: 2489-97. (Pubitemid 351521825)
13. Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S, Phokaew C, Triratanachat S, Trivijitsilp P, Termrungruanglert W, Tresukosol D, Niruthisard S, Mutirangura A,. Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer 2006; 6: 1-9.
14. Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, Lieber A, Kiviat N,. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 114-23.
15. Overmeer RM, Henken FE, Snijders PJ, Claassen-Kramer D, Berkhof J, Helmerhorst TJ, Heideman DA, Wilting SM, Murakami Y, Ito A, Meijer CJ, Steenbergen RD,. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J Pathol 2008; 215: 388-97.
16. Bulkmans NW, Rozendaal L, Snijders PJ, Voorhorst FJ, Boeke AJ, Zandwijken GR, van Kemenade FJ, Verheijen RH, Groningen K, Boon ME, Keuning HJ, van BM, et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 2004; 110: 94-101. (Pubitemid 38507208)
17. da Gloria Mattosinho de Castro Ferraz M, Nicolau SM, Stavale JN, Focchi J, Castelo A, Dores GB, Mielzynska-Lohnas I, Lorincz A, Rodrigues dL,. Cervical biopsy-based comparison of a new liquid-based thin-layer preparation with conventional Pap smears. Diagn Cytopathol 2004; 30: 220-6. (Pubitemid 38420237)
18. Bulk S, van Kemenade FJ, Rozendaal L, Meijer CJ,. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004; 57: 388-93. (Pubitemid 38446257)
19. Vereniging van Integrale Kankercentra. Dutch guideline: treatment of Cervical Intra-epithelial Neoplasia (CIN) according to Werkgroep Oncologische Gyneacologie. 2004. Available at:.
20. de Wilde J, Kooter JM, Overmeer RM, Claassen-Kramer D, Meijer CJ, Snijders PJ, Steenbergen RD,. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis. BMC Cancer 2010; 10: 1-14.
21. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM,. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 35: 791-5. (Pubitemid 27083888)
22. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ,. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779-87. (Pubitemid 34208623)
23. Kagan J, Srivastava S, Barker PE, Belinsky SA, Cairns P,. Towards clinical application of methylated DNA sequences as cancer biomarkers: a joint NCI's EDRN and NIST workshop on standards, methods, assays, reagents and tools. Cancer Res 2007; 67: 4545-9. (Pubitemid 46910155)
24. Harden SV, Guo Z, Epstein JI, Sidransky D,. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 2003; 169: 1138-42. (Pubitemid 36188189)
25. Buffart TE, Overmeer RM, Steenbergen RD, Tijssen M, van Grieken NC, Snijders PJ, Grabsch HI, van de V, Carvalho B, Meijer GA,. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer 2008; 99: 1802-7.
26. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW,. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28: E32 I-VIII.
27. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, McIntosh MW, Young AM, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 2005; 97: 273-82. (Pubitemid 40310275)
28. Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C,. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecol Oncol 2010; 116: 99-104.
29. Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF, Wang SS,. Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol 2007; 107: 549-53. (Pubitemid 350160871)